TITLE

Issuers Pull 15 IPO Filings

AUTHOR(S)
Tunick, Britt Erica
PUB. DATE
August 2004
SOURCE
Investment Dealers' Digest;8/2/2004, Vol. 70 Issue 31, p12
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the decline in investors' confidence in the initial public offering (IPO) market in the U.S. Alternative of venture capital backing to the financial initiative; Turbulence of stock prices for the biotechnology sector; Reasons for withdrawal of IPO filings.
ACCESSION #
13999534

 

Related Articles

  • Leaving Money on the Table in Venture-Backed biotechnology IPOs. Jeppsson, Hans // Journal of Commercial Biotechnology;Oct2016, Vol. 22 Issue 4, p27 

    This study analyzes first-day returns (underpricing) for venture-backed biotechnology IPOs during 1980 through 2015. The result of this study shows that the average first-day return was 17.5 percent, which translates into an amount equal to $6.3 billion that was left on the table - nearly triple...

  • Companies jostle for access to public markets. Bouchie, Aaron // Nature Biotechnology;Dec2003, Vol. 21 Issue 12, p1413 

    Discusses the initial spate of initial public offerings (IPOs) by the United States biotech industry in October 2003. List of United States Biotechnology companies that have gone public since October 8, 2003; Lukewarm response of investors to fluctuations in share prices; Cautious optimism on...

  • Companies Hope to Peer Through IPO Window. Webb, Marion // San Diego Business Journal;2/14/2005, Vol. 26 Issue 7, p3 

    This article focuses on private biotechnology companies which are scheduled to make their public debut in 2005. San Diego, California-based Favrille Inc. is among the first batch of private biotech companies which has opened it's initial public offering to investors. Reports suggest that the...

  • IPO Stock Watch: Biotechs Struggle To Get Out Door. BRIAN DEAGON // Investors Business Daily;7/25/2014, p00 

    Two biotech IPOs that launched Friday had to price below their estimated range in order to draw investors in, though the sector overall remains hot.

  • The effects of venture capitalist affiliation to underwriters on short- and long-term performance in French IPOs. Chahine, Salim; Filatotchev, Igor // Global Finance Journal;Apr2008, Vol. 18 Issue 3, p351 

    Abstract: This paper explores the signalling and monitoring effects of venture capital (VC) backing and venture capitalist affiliation to lead underwriters on performance of IPOs in France. IPOs in which VCs are affiliated to lead underwriters (i.e., affiliated VCs) have lower underpricing than...

  • We're in the MONEY. Schliesman, Kyle // Inside Tucson Business;3/24/2003, Vol. 12 Issue 41, p1 

    Reports on the venture capital raised in Tucson, Arizona. Decline in the investments by corporations; Lack of opportunity in the initial public offering market; Responsibilities of venture capitalists.

  • Biotech Sector Continues Its Torrid Pace in Third Quarter. Winter, Peter // BioWorld Insight;9/30/2013, Vol. 21 Issue 40, p1 

    The article focuses on the performance of the U.S. biotech companies in the capital market in the third quarter of 2013. It states that 53 large capitalized companies have their share prices above an average of 27 percent in the third quarter. It mentions that 29 companies raised 2.2 billion...

  • Venture Industry Takes Chances in Stock Market Frenzy. Patta, Gig // San Diego Business Journal;05/01/2000, Vol. 21 Issue 18, p22 

    Reports on the concern by venture capital firms over the drop in the prices of Internet and biotechnology stocks they have invested in. Drop in initial public offerings of companies such as MP3.com and Sequenom; Establishment of venture capital firms and incubators to take advantage of the...

  • New era promises a sweeter pill. Pinniger, David // Fund Strategy;6/7/2010, p20 

    The article focuses on the opportunities offered by the biotechnology industry in providing high returns of investments. It indicates that the high returns of the biotechnology sector is triggered by the patent expiry cycle and rising competition of generic manufacturers. It shows that the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics